FDA advisory panel endorses Emory-created antiviral Molnupiravir to treat COVID-19

The Food and Drug Administration (FDA) advisory board voted to recommend that the government authorize Molnupiravir, an antiviral pill discovered by Emory University scientists, for Emergency Use Authorization to treat COVID-19 on Nov. 30.  Molnupiravir works by causing mutations in the SARS-CoV-2 virus during replication. In its clinical trials, Molnupiravir was found to be 30% effective at [...]

Read More

Emory professor discovers biological studies often misinterpret sex-based data

Emory Professor of Psychology Donna Maney and Yesenia Garcia-Sifuentes (26G), a student in Emory’s Graduate Program in Neuroscience, published a study on Nov. 2 which detailed misreporting of sex differences in biological sciences.  According to Maney, there has been a push for all clinical and preclinical research to include males and females over the past [...]

Read More

Emory announces new waste management partner

Emory University announced a new waste management partnership with Goodr on Nov. 16, a compost and landfill company that also serves Hartsfield-Jackson Atlanta International Airport and the Georgia World Congress Center.  Chief Climate Change Officer and Associate Vice President Ciannet Howett said she hopes the partnership will help achieve the University’s goal of zero landfill [...]

Read More

Emory, Georgia Tech researchers develop AI-tool to predict COVID-19 symptoms

Researchers at Emory and the Georgia Institute of Technology (Georgia Tech) published a paper on Oct. 21 detailing an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest specific FDA-approved drugs.  These researchers developed MOATAI-VIR (Mode of Action proteins and Targeted therapeutic discovery driven by Artificial Intelligence for Viruses) in the hopes [...]

Read More